INITIAL DRUG TREATMENT IN PARKINSON'S DISEASE Reply

被引：0

作者：

Muzerengi, Sharon ^{[1
]}

Clarke, Carl E. ^{[1
]}

机构：

[1] Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Birmingham B15 2TT, W Midlands, England

来源：

BMJ-BRITISH MEDICAL JOURNAL | 2015年 / 351卷

关键词：

D O I：

10.1136/bmj.h5846

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：1

共 5 条

[1] INITIAL DRUG TREATMENT IN PARKINSON'S DISEASE Reboxetine has no antidepressant effect at all [J].

Braithwaite, Richard .

BMJ-BRITISH MEDICAL JOURNAL, 2015, 351

[2] INITIAL DRUG TREATMENT IN PARKINSON'S DISEASE Review on initial drug treatment in Parkinson's disease did not mention entacapone [J].

Elrington, Giles M. .

BMJ-BRITISH MEDICAL JOURNAL, 2015, 351

[3] Initial drug treatment in Parkinson's disease [J].

Muzerengi, Sharon ;

Clarke, Carl E. .

BMJ-BRITISH MEDICAL JOURNAL, 2015, 351

[4] Initiating Levodopa/Carbidopa Therapy With and Without Entacapone in Early Parkinson Disease The STRIDE-PD Study [J].

Stocchi, Fabrizio ;

Rascol, Olivier ;

Kieburtz, Karl ;

Poewe, Werner ;

Jankovic, Joseph ;

Tolosa, Eduardo ;

Barone, Paulo ;

Lang, Anthony E. ;

Olanow, C. Warren .

ANNALS OF NEUROLOGY, 2010, 68 (01) :18-27

[5]

The National Institute for Health and Clinical Excellence (NICE), Depression in adults with a chronic physical health problem: recognition and management

← 1 →